OHE is pleased to announce that Dr Francois Maignen has joined the team as Head of Operational Research and Data Analysis. Francois’s principal areas of expertise are in the clinical development (methodology of clinical trials) and regulation of medicines for human use.
OHE is seeking to recruit a well-qualified, highly motivated and energetic economist, with particular strengths in the economics of industrial organisation and regulation. The economist will contribute to research and consultancy activities.
The challenge of globalisation heads Towse's list of four core targets for ISPOR.
OHE’s Director, Adrian Towse, is President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for the 2014–15 term, beginning 1 July. His 3rd June incoming president's address to the plenary session at the 19th Annual International Meeting is reproduced below.